Esperity empowers patients by building digital health products that put patients at the centre of pharmaceutical strategy, clinical research, and healthcare communities. Founded in Brussels in 2014, we work with pharmaceutical companies, patient organisations, and clinical trial teams across Europe and beyond — providing the technology infrastructure that makes patient engagement scalable, measurable, and genuinely impactful. Our products span four areas: TrialsConnect — a clinical trial matching and awareness platform that connects patients, patient organizations, sponsors and HCPs to relevant trials. Esperity Health — white-label patient support apps and digital health tools built for pharma-sponsored disease awareness and adherence programmes. Esperity Community — branded patient communities, ambassador programmes, and patient association platforms that give patients a sustained voice beyond a single touchpoint. Includes Esperity Ambassador, our patient advocacy programme framework. AI Ready Patient Engagement — training and implementation support helping pharma teams and patient organisations use AI tools responsibly and effectively in their patient engagement work. We are a technology company with a consulting mindset. Every product we build is informed by real patient insight — through our sister brand PatientCentrics, which specialises in patient research and engagement consulting. Our founding team combines biomedical engineering, nuclear medicine, and patient engagement expertise. We build products we would be comfortable putting in front of the patients we work with. 🌐 esperity.com
Looking for a particular Esperity employee's phone or email?
The Esperity annual revenue was $1 million in 2026.
Mitchell Silva is the Co-Founder of Esperity.
5 people are employed at Esperity.
The NAICS codes for Esperity are [62199, 62, 6219, 621].
The SIC codes for Esperity are [809, 80].